9 years; range: 17–84 years) with PTB from Shandong Chest Hospital, May 2010–June 2012. According to American Tuberculosis Panobinostat mw Society criteria, patients were diagnosed on the history, clinical symptoms and signs, chest X-ray, sputum smear test and tuberculin skin test. No extrapulmonary tuberculosis was detected. Peripheral blood was collected before antituberculosis therapy. Subjects with other infectious diseases, immunological or autoimmune diseases as well as other diseases may affect the immune system were excluded. According to sputum smear

test, we subdivided patients into smear positive group and negative group. Healthy control group.  A total of 200 unrelated healthy controls (107 men and 93 women; mean age: 37.1 years; range: 21–80 years) with the positive history of tuberculin skin test were recruited from Shandong Chest Hospital, May 2010–June

2012. X-ray did not reveal PTB and all have inoculated with Bacillus Calmette–Guerin vaccine. Patients and controls were matched for genders, ages and ethnicity. All the controls with other infectious diseases, immunological or autoimmune diseases as well as other diseases may affect the immune system were excluded. This study had ethical approval from the Hospital Ethics Committee, and an informed consent was obtained from each individual. ICG-001 datasheet Genomic DNA isolation.  According to the manufacturer’s instructions, genomic DNA was extracted from 5 ml ethylene diamine tetraacetic acid (EDTA) anticoagulated peripheral blood using TIANamp Blood DNA kit (Tiangen Biotech, Beijing, China) and stored at −20 °C. We determined the integrity and quantity of DNA samples using UV spectrophotometer and DNA concentration was adjusted to 50 ng/μl. KIR genotyping.  Genotyping of KIR was conducted by SSP–PCR method, which was performed to detect the presence or absence of 12 known KIR genes, including 2DL1-3, 2DL5, 2DS1-5, 3DL1, 3DS1 and 1D. All primers (Bo Ya Biotechnology Co. Ltd, Shanghai, China) were validated and confirmed. The primers of 2DL1-3, 2DL5, 2DS1-5, Docetaxel cost 3DL1 and 3DS1 were designed based on primer sites described by

Martin et al. [12], and the primers of 1D were described by Hsu et al. [13]; 0.5 μl of genomic DNA was amplified in a volume of approximately 20-μl system including 6 μl primers, 6.6 μl PCR loading dye mix (Takara, Kyoto, Japan), 6.9 μl RNase Free (Takara). PCR was performed on Gene Amp PCR system 9700 (Applied Biosystems, Foster City, CA, USA). After an initial denaturation step at 94 °C for 1 min, PCR was used to increase specificity of primers annealing during the first 10 cycles, consisting of a melting temperature of 94 °C for 30 s and an annealing temperature of 65 °C for 30 s, followed by 20 cycles were performed at a melting temperature of 94 °C for 30 s, an annealing temperature of 62 °C for 30 s and an extension temperature of 72 °C for 40 s. At last, an extra extension step was preformed at 72 °C.